首页> 美国卫生研究院文献>Antimicrobial Agents and Chemotherapy >Antimalarial action of hydroxamate-based iron chelators and potentiation of desferrioxamine action by reversed siderophores.
【2h】

Antimalarial action of hydroxamate-based iron chelators and potentiation of desferrioxamine action by reversed siderophores.

机译:异羟肟酸酯基铁螯合剂的抗疟作用和反铁载体增强去铁胺作用的效果。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Hydroxamate-based chelators of iron are potent inhibitors of in vitro growth of Plasmodium falciparum. Two types of such chelators, the natural desferrioxamine and the synthetic reversed siderophore RSFileum2, are prototypes of antimalarial agents whose action spectra differ in the speed of action, stage dependence, and degree of reversibility of effects. This work explores the possibility of improving the antimalarial efficacy of these agents by using them in various combinations on in vitro cultures of P. falciparum. Growth assessment was based both on total nucleic acid synthesis and on parasitemia. The results indicate that the synthetic reversed siderophore more than complements the antimalarial action of desferrioxamine when applied during either ring, trophozoite, or mixed stages. The combined drug effects were significantly higher than the additive effect of the individual drugs. Qualitatively similar results were obtained for both reversible effects and irreversible (i.e., sustained) effects. Following an 8-h window of exposure the combined drug treatment caused parasite growth arrest and prevented its recovery, even 3 days after the treatment. The fact that such a combination of iron chelators displays a wider action spectrum than either drug alone has implications for the design of chemotherapy regimens.
机译:铁的基于异羟肟酸酯的螯合剂是恶性疟原虫体外生长的有效抑制剂。这类螯合剂的两种类型,天然的去铁草胺和合成的反向铁载体RSFileum2,是抗疟剂的原型,其作用谱在作用速度,阶段依赖性和作用的可逆性上有所不同。这项工作探索了通过在恶性疟原虫的体外培养物中以各种组合使用它们来提高这些药物的抗疟疾功效的可能性。生长评估基于总核酸合成和寄生虫血症。结果表明,当在环,滋养体或混合阶段施用时,合成的反向铁载体比去铁胺的抗疟作用更为有效。组合药物作用明显高于单个药物的累加作用。对于可逆作用和不可逆(即持续)作用均获得了定性相似的结果。经过8小时的暴露窗口后,即使在治疗后3天,联合药物治疗也会导致寄生虫生长停滞并阻止其恢复。铁螯合剂的这种组合比单独使用任何一种药物都具有更宽的作用范围这一事实对化疗方案的设计产生了影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号